Table 3 Drug therapy details (n = 1176)
Endocrine therapy (yes/no) | 796 (68%)/380 (32%) |
|---|---|
Tamoxifen + LHRH agonist | 106 |
Tamoxifen | 289 |
Anastrozole | 351 |
Letrozole | 35 |
Exemestane | 13 |
Others | 2 |
Concurrent endocrine therapy (yes/no) | 765 (96%)/31 (4%) |
Chemotherapy (yes/no) | 607 (52%)/569 (48%) |
Preoperative | 231 |
Postoperative | 342 |
Pre and postoperative | 32 |
unknown | 2 |
Anthracycline + Taxiane-based regimen | 471 |
Anthracycline-based regimen | 119 |
Taxiane-based regimen | 10 |
Others | 7 |
Trastuzumab (yes/no) | 68 (6%)/1108 (94%) |